EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Sample Adequacy Control for Negative Molecular Results: An Integrated Specimen-Process Framework to Strengthen Result Interpretation

Ivan Brukner, Shaun Eintracht, Matthew T. Oughton

LabMed · 30.06.2026 · 3 (3) · 16

DOI: 10.3390/labmed3030016 ↗

Kurz gefasst

Fachartikel in der Zeitschrift LabMed, online erschienen am 30.06.2026. Verfasst von Ivan Brukner und 2 weiteren Autor:innen. Die Arbeit nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Sample adequacy control (SAC) is a validated specimen-specific marker or metric, threshold, and reporting rule used to decide whether a negative molecular result is supported by the submitted specimen. SAC is not simply a cell-count or biomass check. Depending on specimen type and target, an unsupported negative result may reflect insufficient or nonrepresentative material, adequacy-marker degradation, inefficient transfer or extraction, matrix-associated inhibition, or mismatch between marker and anatomical compartment. SAC is therefore best understood as an integrated specimen-process adequacy control for negative-result interpretation. Its result should be reported as valid, borderline, or invalid for the intended negative interpretation, not as detected/not detected like the disease-specific biomarker. This perspective synthesizes quantitative polymerase chain reaction (qPCR) control guidance, preanalytical-quality literature, respiratory and enteric sampling studies, human papillomavirus (HPV) evidence, cartridge-assay precedents, and decentralized workflows. Direct prospective evidence that SAC improves patient or epidemiologic outcomes remains limited; available evidence is outcome-adjacent or operational, including HPV cellularity-control associations, Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) and Ebola cartridge precedents, respiratory workflows showing lower pathogen positivity at higher SAC quantification cycle (Cq) strata, and reporting rules that change validity or recollection decisions. We propose a risk-based framework for selecting, validating, reporting, and monitoring SAC, with particular value in direct-amplification, point-of-care, and self-collection workflows where preanalytical failures affect negative-result interpretation.

Zitieren

APA

Brukner, I., Eintracht, S., & Oughton, M. T. (2026). Sample Adequacy Control for Negative Molecular Results: An Integrated Specimen-Process Framework to Strengthen Result Interpretation. LabMed, 3(3), 16. https://doi.org/10.3390/labmed3030016

Vancouver

Brukner I, Eintracht S, Oughton MT. Sample Adequacy Control for Negative Molecular Results: An Integrated Specimen-Process Framework to Strengthen Result Interpretation. LabMed. 2026;3(3):16. doi:10.3390/labmed3030016

BibTeX
@article{Brukner2026,
  author = {Brukner, Ivan and Eintracht, Shaun and Oughton, Matthew T.},
  title = {Sample Adequacy Control for Negative Molecular Results: An Integrated Specimen-Process Framework to Strengthen Result Interpretation},
  journal = {LabMed},
  year = {2026},
  volume = {3},
  number = {3},
  pages = {16},
  doi = {10.3390/labmed3030016}
}
Kostenlos starten →